Burn Ointment Market is estimated to be valued at USD 1,160.6 Mn in 2025 and is expected to reach USD 1,756.7 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.
The global market for burn ointments is expanding due to the rising prevalence of burns, both severe and mild, happening at home, in industries, or even in the military setting. The most important drivers are increasing popularity of advanced wound management, availability of potent topical medicines, and growing accessibility of non-prescription medications.
|
Current Event |
Description and its impact |
|
Rising Incidence of Burn Injuries |
|
|
Product Launches Featuring Advanced Formulations |
|
|
Healthcare Awareness Campaigns and Government Initiatives |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The rise in the number of burn cases globally, particularly in developing nations such as China, is one of the major growth drivers for the market for burn ointment. In September 2022, an open-access peer-reviewed journal named Burns & Trauma published a study on the epidemiology of burns in Mainland China during 2009-2018 and observed that 222,480 burn patients were reported during this time.
Increasing investment in research and development activities to develop innovative treatments for burns also fuels market growth. For example, Hospices Civils de Lyon, a leading hospital in France, conducted a clinical trial in January 2023 to assess an arrangement of second-degree fibrinous burns treatment with silver sulphadiazine ointment. The test will compare the effectiveness of the treatment and should be completed by January 2026.
By product type, the topical antibiotics segment is anticipated to lead the global burn ointment market, commanding the largest market share in 2025. This dominance is largely driven by the widespread availability and trusted efficacy of these products in both professional medical and home-use scenarios. Topical antibiotics in the form of products containing ingredients like bacitracin, neomycin, and polymyxin B are usually prescribed and recommended since they have a known application in the prevention and cure of infections from minor and serious burns.
To learn more about this report, Download Free Sample
North America is set to lead the world in the burn ointment market, with a massive 40% share by the year 2025. The region's dominance is primarily due to the highly developed healthcare infrastructure, rising awareness among consumers, and extensive availability of over-the-counter and prescription burn care products. One key driver of this growth is the rising number of awareness programs focused on educating people on burn prevention and treatment.
For example, in February 2022, National Burn Awareness Week was organized by the American Burn Association from February 6 to February 12, during which fire and life safety educators throughout the United States joined efforts to spread awareness about burns and prevention messages across respective communities. These kinds of efforts have greatly raised awareness and response of the public towards burn injuries, leading to early and proper treatment.
The United States dominates the world's burn ointment market, supported by a strong healthcare system, extensive availability of sophisticated wound care products, and strong public awareness of burn injury treatment. The nation's leadership is supplemented by continuous R&D activities, mutual alliances among medical centers and pharma firms, and extensive distribution networks for facilitating easy availability of over-the-counter and prescription ointments.
China is emerging as a major player in the burn ointment industry with its huge population, growing incidence of burns, and growing health accessibility. In September 2022, Burns & Trauma released a study of 222,480 cases of burns in Mainland China for the period 2009-2018, thus reflecting the growing demand for effective burn care and wound care solutions.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1,160.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.1% | 2032 Value Projection: | USD 1,756.7 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Smith & Nephew PLC, Wisconsin Pharmacal Company, Johnson & Johnson, Pfizer Inc., Cipla Ltd., Mankind Pharma Ltd., Dr. Morepen Ltd., GlaxoSmithKline PLC and MediWound |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
About Author
Vipul Patil is a dynamic management consultant with 6 years of dedicated experience in the pharmaceutical industry. Known for his analytical acumen and strategic insight, Vipul has successfully partnered with pharmaceutical companies to enhance operational efficiency, cross broader expansion, and navigate the complexities of distribution in markets with high revenue potential.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
